Drug discovery, toxicology, and developmental research depend on image-based biological models to understand how chemical, genetic, and environmental perturbations affect living systems. When development goes wrong, the damage is written into the body's shape — a trained biologist can look at a malformed embryo and tell which signalling pathway was disrupted.

Reading that phenotype remains one of the most direct ways to find out what a substance does to a living organism. Extracting it at scale is the bottleneck: manual evaluation is labour-intensive, hard to standardise between evaluators, and the high-content imaging platforms that automate it demand infrastructure and expertise most labs don't have.

Morphomics addresses this with an integrated platform — MorphoScan, a compact automated imaging system that sits inside a standard incubator and records time-lapse images of embryos and organoids, combined with four AI modules that transform those images into quantitative phenotypic information.